The Potential for Big Data in Type 2 Diabetes

Archives of Community Medicine and Public Health
doi 10.17352/2455-5479.000051
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Peertechz Publications Private Limited

Related search

Big Data and Diabetes: The Applications of Big Data for Diabetes Care Now and in the Future

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Big Challenges: Obesity and Type 2 Diabetes in Children and Adolescents

World Journal of Pediatrics
Child HealthPediatricsPerinatology
2019English

Lixisenatide: Evidence for Its Potential Use in the Treatment of Type 2 Diabetes

Core Evidence
MedicineReviewsReferencesPharmacology
2011English

Potential Impact on Lipoprotein Subfractions in Type 2 Diabetes

Clinical Medicine Insights: Endocrinology and Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Glucokinase and the Potential of Glucokinase Activation in Type 2 Diabetes

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Identification of Determinants of Progression to Type 2 Diabetes Using Electronic Health Records and ‘Big Data’ Analytics

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Potential of Liraglutide in the Treatment of Patients With Type 2 Diabetes

Vascular Health and Risk Management
2009English

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2019English

Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients

Drugs in Context
Molecular MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy